admin
For Indian pharmaceutical companies looking at export markets, Good Manufacturing Practice certification is the first question every buyer asks. Two of the most common frameworks are WHO-GMP and EU-GMP. Both set out how medicines should be produced and controlled, yet the markets they unlock and the investment they require are quite different.
What WHO-GMP Covers
WHO-GMP guidelines are published by the World Health Organization and are widely accepted across Africa, Southeast Asia, Latin America and CIS countries. In India, WHO-GMP certification is issued under the WHO certification scheme through the national and state regulators. It is often the minimum expectation for tender supply and product registration in emerging markets.
- Recognised by many ministries of health and procurement agencies
- Focus on documentation, quality control and hygiene
- Achievable for most well run facilities with targeted upgrades
What EU-GMP Adds
EU-GMP is the standard enforced by European regulators and is aligned with PIC/S. It places much greater emphasis on facility design, data integrity, validation and a mature pharmaceutical quality system. Sites that pass an EU inspection are often viewed favourably by regulators in other highly regulated markets as well.
EU-GMP is less a certificate and more a culture. Facilities that succeed treat it as a continuous way of working rather than a one time audit.
Key Differences at a Glance
| Area | WHO-GMP | EU-GMP |
|---|---|---|
| Typical markets | Africa, Asia, LATAM, CIS | European Union and PIC/S aligned markets |
| Inspection depth | Moderate | Very detailed |
| Data integrity focus | Growing | Central requirement |
| Upgrade investment | Lower | Significantly higher |
How to Choose Your Path
- Map your priority export markets for the next three to five years.
- Run a gap assessment of your facility against both frameworks.
- Estimate the capex and timeline for each upgrade route.
- Plan a phased approach, starting with WHO-GMP and building towards EU-GMP where the business case supports it.
WHO-GMP is the practical gateway to most emerging markets, while EU-GMP positions a facility for regulated markets and premium partnerships. A clear market strategy should drive which certification you pursue first.
Need help assessing your facility? Our regulatory and turnkey teams can carry out a detailed gap analysis and build a realistic upgrade roadmap.
